Blood-brain barrier transport mechanisms for antibody therapeutics¶
Notebook ID: nb-sda-2026-04-01-gap-008 · Analysis: sda-2026-04-01-gap-008 · Generated: 2026-04-20T08:56:48
Research question¶
Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% brain penetrance. Engineering improved BBB transcytosis via transferrin receptor, LRP1, or novel shuttle peptides could dramatically improve efficacy.
Approach¶
This notebook is generated programmatically from real Forge tool calls and SciDEX debate data. Forge tools used: PubMed Search, MyGene, STRING PPI, Reactome pathways, Enrichr.
Debate Summary¶
Quality score: 0.91 · Rounds: 4
1. Target gene annotations (MyGene + Human Protein Atlas)¶
In [1]:
import pandas as pd
ann_rows = [{'gene': 'ABCB1', 'name': 'ATP binding cassette subfamily B member 1', 'protein_class': "['Cancer-related genes', 'CD markers', 'Disease related gene", 'disease_involvement': "['Cancer-related genes', 'Disease variant']"}, {'gene': 'APOE', 'name': 'apolipoprotein E', 'protein_class': "['Cancer-related genes', 'Candidate cardiovascular disease g", 'disease_involvement': "['Alzheimer disease', 'Amyloidosis', 'Cancer-related genes', 'Disease variant', "}, {'gene': 'AQP4', 'name': 'aquaporin 4', 'protein_class': "['Human disease related genes', 'Metabolic proteins', 'Predi", 'disease_involvement': "['Disease variant']"}, {'gene': 'CAV1', 'name': 'caveolin 1', 'protein_class': "['Cancer-related genes', 'Disease related genes', 'Human dis", 'disease_involvement': "['Cancer-related genes', 'Congenital generalized lipodystrophy', 'Diabetes melli"}, {'gene': 'CLDN5', 'name': 'claudin 5', 'protein_class': "['Predicted membrane proteins', 'Transporters']", 'disease_involvement': '—'}, {'gene': 'FCGRT', 'name': 'Fc gamma receptor and transporter', 'protein_class': "['FDA approved drug targets', 'Predicted intracellular prote", 'disease_involvement': "['FDA approved drug targets']"}, {'gene': 'LDLR', 'name': 'low density lipoprotein receptor', 'protein_class': "['Disease related genes', 'Human disease related genes', 'Me", 'disease_involvement': "['Disease variant']"}, {'gene': 'LRP1', 'name': 'LDL receptor related protein 1', 'protein_class': "['Candidate cardiovascular disease genes', 'CD markers', 'Di", 'disease_involvement': "['Disease variant']"}, {'gene': 'MTNR1A', 'name': 'melatonin receptor 1A', 'protein_class': "['FDA approved drug targets', 'G-protein coupled receptors',", 'disease_involvement': "['FDA approved drug targets']"}, {'gene': 'MTNR1B', 'name': 'melatonin receptor 1B', 'protein_class': "['FDA approved drug targets', 'G-protein coupled receptors',", 'disease_involvement': "['FDA approved drug targets']"}, {'gene': 'OCLN', 'name': 'occludin', 'protein_class': "['Disease related genes', 'Human disease related genes', 'Po", 'disease_involvement': "['Disease variant']"}, {'gene': 'TFR1', 'name': 'transferrin receptor', 'protein_class': '—', 'disease_involvement': '—'}]
pd.DataFrame(ann_rows)
| gene | name | protein_class | disease_involvement | |
|---|---|---|---|---|
| 0 | ABCB1 | ATP binding cassette subfamily B member 1 | ['Cancer-related genes', 'CD markers', 'Diseas... | ['Cancer-related genes', 'Disease variant'] |
| 1 | APOE | apolipoprotein E | ['Cancer-related genes', 'Candidate cardiovasc... | ['Alzheimer disease', 'Amyloidosis', 'Cancer-r... |
| 2 | AQP4 | aquaporin 4 | ['Human disease related genes', 'Metabolic pro... | ['Disease variant'] |
| 3 | CAV1 | caveolin 1 | ['Cancer-related genes', 'Disease related gene... | ['Cancer-related genes', 'Congenital generaliz... |
| 4 | CLDN5 | claudin 5 | ['Predicted membrane proteins', 'Transporters'] | — |
| 5 | FCGRT | Fc gamma receptor and transporter | ['FDA approved drug targets', 'Predicted intra... | ['FDA approved drug targets'] |
| 6 | LDLR | low density lipoprotein receptor | ['Disease related genes', 'Human disease relat... | ['Disease variant'] |
| 7 | LRP1 | LDL receptor related protein 1 | ['Candidate cardiovascular disease genes', 'CD... | ['Disease variant'] |
| 8 | MTNR1A | melatonin receptor 1A | ['FDA approved drug targets', 'G-protein coupl... | ['FDA approved drug targets'] |
| 9 | MTNR1B | melatonin receptor 1B | ['FDA approved drug targets', 'G-protein coupl... | ['FDA approved drug targets'] |
| 10 | OCLN | occludin | ['Disease related genes', 'Human disease relat... | ['Disease variant'] |
| 11 | TFR1 | transferrin receptor | — | — |
2. GO Biological Process enrichment (Enrichr)¶
In [2]:
go_bp = [{'rank': 1, 'term': 'Positive Regulation Of Protein Binding (GO:0032092)', 'p_value': 3.3208141784205076e-08, 'odds_ratio': 181.20909090909092, 'genes': ['CLDN5', 'LRP1', 'CAV1', 'APOE']}, {'rank': 2, 'term': 'Negative Regulation Of Macromolecule Metabolic Process (GO:0010605)', 'p_value': 4.951657738437225e-08, 'odds_ratio': 78.16495659037095, 'genes': ['CLDN5', 'OCLN', 'LRP1', 'APOE', 'LDLR']}, {'rank': 3, 'term': 'Positive Regulation Of Binding (GO:0051099)', 'p_value': 1.9302450247660253e-07, 'odds_ratio': 114.3735632183908, 'genes': ['CLDN5', 'LRP1', 'CAV1', 'APOE']}, {'rank': 4, 'term': 'Positive Regulation Of Cholesterol Efflux (GO:0010875)', 'p_value': 2.524850480879744e-07, 'odds_ratio': 350.3333333333333, 'genes': ['LRP1', 'CAV1', 'APOE']}, {'rank': 5, 'term': 'Receptor-Mediated Endocytosis (GO:0006898)', 'p_value': 6.28078999266415e-07, 'odds_ratio': 84.19491525423729, 'genes': ['LRP1', 'CAV1', 'APOE', 'LDLR']}, {'rank': 6, 'term': 'Positive Regulation Of Cholesterol Transport (GO:0032376)', 'p_value': 7.347354101262715e-07, 'odds_ratio': 237.61904761904762, 'genes': ['LRP1', 'CAV1', 'APOE']}, {'rank': 7, 'term': 'Regulation Of Cholesterol Efflux (GO:0010874)', 'p_value': 8.104697819497437e-07, 'odds_ratio': 229.41379310344828, 'genes': ['LRP1', 'CAV1', 'APOE']}, {'rank': 8, 'term': 'Positive Regulation Of Protein Catabolic Process In The Vacuole (GO:1904352)', 'p_value': 3.2966149429844506e-06, 'odds_ratio': 1332.3333333333333, 'genes': ['LRP1', 'LDLR']}, {'rank': 9, 'term': 'Cholesterol Transport (GO:0030301)', 'p_value': 3.3811180237045916e-06, 'odds_ratio': 138.47222222222223, 'genes': ['CAV1', 'APOE', 'LDLR']}, {'rank': 10, 'term': 'Endocytosis (GO:0006897)', 'p_value': 3.6038790657607e-06, 'odds_ratio': 53.52162162162162, 'genes': ['LRP1', 'CAV1', 'APOE', 'LDLR']}]
go_df = pd.DataFrame(go_bp)[['term','p_value','odds_ratio','genes']]
go_df['p_value'] = go_df['p_value'].apply(lambda p: f'{p:.2e}')
go_df['odds_ratio'] = go_df['odds_ratio'].round(1)
go_df['term'] = go_df['term'].str[:60]
go_df['n_hits'] = go_df['genes'].apply(len)
go_df['genes'] = go_df['genes'].apply(lambda g: ', '.join(g))
go_df[['term','n_hits','p_value','odds_ratio','genes']]
| term | n_hits | p_value | odds_ratio | genes | |
|---|---|---|---|---|---|
| 0 | Positive Regulation Of Protein Binding (GO:003... | 4 | 3.32e-08 | 181.2 | CLDN5, LRP1, CAV1, APOE |
| 1 | Negative Regulation Of Macromolecule Metabolic... | 5 | 4.95e-08 | 78.2 | CLDN5, OCLN, LRP1, APOE, LDLR |
| 2 | Positive Regulation Of Binding (GO:0051099) | 4 | 1.93e-07 | 114.4 | CLDN5, LRP1, CAV1, APOE |
| 3 | Positive Regulation Of Cholesterol Efflux (GO:... | 3 | 2.52e-07 | 350.3 | LRP1, CAV1, APOE |
| 4 | Receptor-Mediated Endocytosis (GO:0006898) | 4 | 6.28e-07 | 84.2 | LRP1, CAV1, APOE, LDLR |
| 5 | Positive Regulation Of Cholesterol Transport (... | 3 | 7.35e-07 | 237.6 | LRP1, CAV1, APOE |
| 6 | Regulation Of Cholesterol Efflux (GO:0010874) | 3 | 8.10e-07 | 229.4 | LRP1, CAV1, APOE |
| 7 | Positive Regulation Of Protein Catabolic Proce... | 2 | 3.30e-06 | 1332.3 | LRP1, LDLR |
| 8 | Cholesterol Transport (GO:0030301) | 3 | 3.38e-06 | 138.5 | CAV1, APOE, LDLR |
| 9 | Endocytosis (GO:0006897) | 4 | 3.60e-06 | 53.5 | LRP1, CAV1, APOE, LDLR |
In [3]:
import matplotlib.pyplot as plt
import numpy as np
go_bp = [{'rank': 1, 'term': 'Positive Regulation Of Protein Binding (GO:0032092)', 'p_value': 3.3208141784205076e-08, 'odds_ratio': 181.20909090909092, 'genes': ['CLDN5', 'LRP1', 'CAV1', 'APOE']}, {'rank': 2, 'term': 'Negative Regulation Of Macromolecule Metabolic Process (GO:0010605)', 'p_value': 4.951657738437225e-08, 'odds_ratio': 78.16495659037095, 'genes': ['CLDN5', 'OCLN', 'LRP1', 'APOE', 'LDLR']}, {'rank': 3, 'term': 'Positive Regulation Of Binding (GO:0051099)', 'p_value': 1.9302450247660253e-07, 'odds_ratio': 114.3735632183908, 'genes': ['CLDN5', 'LRP1', 'CAV1', 'APOE']}, {'rank': 4, 'term': 'Positive Regulation Of Cholesterol Efflux (GO:0010875)', 'p_value': 2.524850480879744e-07, 'odds_ratio': 350.3333333333333, 'genes': ['LRP1', 'CAV1', 'APOE']}, {'rank': 5, 'term': 'Receptor-Mediated Endocytosis (GO:0006898)', 'p_value': 6.28078999266415e-07, 'odds_ratio': 84.19491525423729, 'genes': ['LRP1', 'CAV1', 'APOE', 'LDLR']}, {'rank': 6, 'term': 'Positive Regulation Of Cholesterol Transport (GO:0032376)', 'p_value': 7.347354101262715e-07, 'odds_ratio': 237.61904761904762, 'genes': ['LRP1', 'CAV1', 'APOE']}, {'rank': 7, 'term': 'Regulation Of Cholesterol Efflux (GO:0010874)', 'p_value': 8.104697819497437e-07, 'odds_ratio': 229.41379310344828, 'genes': ['LRP1', 'CAV1', 'APOE']}, {'rank': 8, 'term': 'Positive Regulation Of Protein Catabolic Process In The Vacuole (GO:1904352)', 'p_value': 3.2966149429844506e-06, 'odds_ratio': 1332.3333333333333, 'genes': ['LRP1', 'LDLR']}]
terms = [t['term'][:45] for t in go_bp][::-1]
neglogp = [-np.log10(max(t['p_value'], 1e-300)) for t in go_bp][::-1]
fig, ax = plt.subplots(figsize=(9, 4.5))
ax.barh(terms, neglogp, color='#4fc3f7')
ax.set_xlabel('-log10(p-value)')
ax.set_title('Top GO:BP enrichment (Enrichr)')
ax.grid(axis='x', alpha=0.3)
plt.tight_layout(); plt.show()
3. STRING protein interaction network¶
In [4]:
ppi = [{'protein1': 'LRP1', 'protein2': 'APOE', 'score': 0.999, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.549, 'dscore': 0.9, 'tscore': 0.982}, {'protein1': 'APOE', 'protein2': 'CAV1', 'score': 0.635, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0, 'dscore': 0, 'tscore': 0.635}, {'protein1': 'APOE', 'protein2': 'LDLR', 'score': 0.783, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.549, 'dscore': 0.54, 'tscore': 0}, {'protein1': 'MTNR1B', 'protein2': 'MTNR1A', 'score': 0.926, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.292, 'dscore': 0.9, 'tscore': 0}, {'protein1': 'CAV1', 'protein2': 'TFRC', 'score': 0.4, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.33, 'dscore': 0, 'tscore': 0.142}, {'protein1': 'CAV1', 'protein2': 'ABCB1', 'score': 0.427, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.423, 'dscore': 0, 'tscore': 0.048}, {'protein1': 'CAV1', 'protein2': 'OCLN', 'score': 0.56, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.124, 'dscore': 0, 'tscore': 0.519}, {'protein1': 'OCLN', 'protein2': 'CLDN5', 'score': 0.99, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0, 'dscore': 0.65, 'tscore': 0.974}]
ppi_df = pd.DataFrame(ppi).sort_values('score', ascending=False)
display_cols = [c for c in ['protein1','protein2','score','escore','tscore'] if c in ppi_df.columns]
print(f'{len(ppi_df)} STRING edges')
ppi_df[display_cols].head(20)
8 STRING edges
| protein1 | protein2 | score | escore | tscore | |
|---|---|---|---|---|---|
| 0 | LRP1 | APOE | 0.999 | 0.549 | 0.982 |
| 7 | OCLN | CLDN5 | 0.990 | 0.000 | 0.974 |
| 3 | MTNR1B | MTNR1A | 0.926 | 0.292 | 0.000 |
| 2 | APOE | LDLR | 0.783 | 0.549 | 0.000 |
| 1 | APOE | CAV1 | 0.635 | 0.000 | 0.635 |
| 6 | CAV1 | OCLN | 0.560 | 0.124 | 0.519 |
| 5 | CAV1 | ABCB1 | 0.427 | 0.423 | 0.048 |
| 4 | CAV1 | TFRC | 0.400 | 0.330 | 0.142 |
In [5]:
import math
ppi = [{'protein1': 'LRP1', 'protein2': 'APOE', 'score': 0.999, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.549, 'dscore': 0.9, 'tscore': 0.982}, {'protein1': 'APOE', 'protein2': 'CAV1', 'score': 0.635, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0, 'dscore': 0, 'tscore': 0.635}, {'protein1': 'APOE', 'protein2': 'LDLR', 'score': 0.783, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.549, 'dscore': 0.54, 'tscore': 0}, {'protein1': 'MTNR1B', 'protein2': 'MTNR1A', 'score': 0.926, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.292, 'dscore': 0.9, 'tscore': 0}, {'protein1': 'CAV1', 'protein2': 'TFRC', 'score': 0.4, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.33, 'dscore': 0, 'tscore': 0.142}, {'protein1': 'CAV1', 'protein2': 'ABCB1', 'score': 0.427, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.423, 'dscore': 0, 'tscore': 0.048}, {'protein1': 'CAV1', 'protein2': 'OCLN', 'score': 0.56, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0.124, 'dscore': 0, 'tscore': 0.519}, {'protein1': 'OCLN', 'protein2': 'CLDN5', 'score': 0.99, 'nscore': 0, 'fscore': 0, 'pscore': 0, 'ascore': 0, 'escore': 0, 'dscore': 0.65, 'tscore': 0.974}]
if ppi:
nodes = sorted({p for e in ppi for p in (e['protein1'], e['protein2'])})
n = len(nodes)
pos = {n_: (math.cos(2*math.pi*i/n), math.sin(2*math.pi*i/n)) for i, n_ in enumerate(nodes)}
fig, ax = plt.subplots(figsize=(7, 7))
for e in ppi:
x1,y1 = pos[e['protein1']]; x2,y2 = pos[e['protein2']]
ax.plot([x1,x2],[y1,y2], color='#888', alpha=0.3+0.5*e.get('score',0))
for name,(x,y) in pos.items():
ax.scatter([x],[y], s=450, color='#ffd54f', edgecolors='#333', zorder=3)
ax.annotate(name, (x,y), ha='center', va='center', fontsize=8, fontweight='bold', zorder=4)
ax.set_aspect('equal'); ax.axis('off')
ax.set_title(f'STRING PPI network ({len(ppi)} edges)')
plt.tight_layout(); plt.show()
4. Reactome pathway footprint¶
In [6]:
pw_rows = [{'gene': 'ABCB1', 'n_pathways': 4, 'top_pathway': 'Abacavir transmembrane transport'}, {'gene': 'APOE', 'n_pathways': 8, 'top_pathway': 'Nuclear signaling by ERBB4'}, {'gene': 'AQP4', 'n_pathways': 2, 'top_pathway': 'Vasopressin regulates renal water homeostasis via Aquaporins'}, {'gene': 'CAV1', 'n_pathways': 8, 'top_pathway': 'Triglyceride catabolism'}, {'gene': 'CLDN5', 'n_pathways': 2, 'top_pathway': 'Tight junction interactions'}, {'gene': 'FCGRT', 'n_pathways': 0, 'top_pathway': '—'}, {'gene': 'LDLR', 'n_pathways': 5, 'top_pathway': 'Cargo recognition for clathrin-mediated endocytosis'}, {'gene': 'LRP1', 'n_pathways': 2, 'top_pathway': 'Scavenging of heme from plasma'}, {'gene': 'MTNR1A', 'n_pathways': 2, 'top_pathway': 'Class A/1 (Rhodopsin-like receptors)'}, {'gene': 'MTNR1B', 'n_pathways': 2, 'top_pathway': 'Class A/1 (Rhodopsin-like receptors)'}, {'gene': 'OCLN', 'n_pathways': 2, 'top_pathway': 'Apoptotic cleavage of cell adhesion proteins'}, {'gene': 'TFR1', 'n_pathways': 0, 'top_pathway': '—'}]
pd.DataFrame(pw_rows).sort_values('n_pathways', ascending=False)
| gene | n_pathways | top_pathway | |
|---|---|---|---|
| 1 | APOE | 8 | Nuclear signaling by ERBB4 |
| 3 | CAV1 | 8 | Triglyceride catabolism |
| 6 | LDLR | 5 | Cargo recognition for clathrin-mediated endocy... |
| 0 | ABCB1 | 4 | Abacavir transmembrane transport |
| 2 | AQP4 | 2 | Vasopressin regulates renal water homeostasis ... |
| 4 | CLDN5 | 2 | Tight junction interactions |
| 7 | LRP1 | 2 | Scavenging of heme from plasma |
| 8 | MTNR1A | 2 | Class A/1 (Rhodopsin-like receptors) |
| 10 | OCLN | 2 | Apoptotic cleavage of cell adhesion proteins |
| 9 | MTNR1B | 2 | Class A/1 (Rhodopsin-like receptors) |
| 5 | FCGRT | 0 | — |
| 11 | TFR1 | 0 | — |
5. Hypothesis ranking (7 hypotheses)¶
In [7]:
hyp_data = [('Dual-Domain Antibodies with Engineered Fc-FcRn Affinity', 0.773), ('Glymphatic System-Enhanced Antibody Clearance Reversal', 0.758), ('Synthetic Biology BBB Endothelial Cell Reprogramming', 0.727), ('Magnetosonic-Triggered Transferrin Receptor Clustering', 0.719), ('Engineered Apolipoprotein E4-Neutralizing Shuttle Pepti', 0.718), ('Circadian-Synchronized LRP1 Pathway Activation', 0.714), ('Piezoelectric Nanochannel BBB Disruption', 0.67)]
titles = [h[0] for h in hyp_data][::-1]
scores = [h[1] for h in hyp_data][::-1]
fig, ax = plt.subplots(figsize=(10, max(8, len(titles)*0.4)))
colors = ['#ef5350' if s >= 0.6 else '#ffa726' if s >= 0.5 else '#66bb6a' for s in scores]
ax.barh(range(len(titles)), scores, color=colors)
ax.set_yticks(range(len(titles))); ax.set_yticklabels(titles, fontsize=7)
ax.set_xlabel('Composite Score'); ax.set_title('Blood-brain barrier transport mechanisms for antibody therapeutics')
ax.grid(axis='x', alpha=0.3)
plt.tight_layout(); plt.show()
6. Score dimension heatmap (top 10)¶
In [8]:
labels = ['Dual-Domain Antibodies with Engineered F', 'Glymphatic System-Enhanced Antibody Clea', 'Synthetic Biology BBB Endothelial Cell R', 'Magnetosonic-Triggered Transferrin Recep', 'Engineered Apolipoprotein E4-Neutralizin', 'Circadian-Synchronized LRP1 Pathway Acti', 'Piezoelectric Nanochannel BBB Disruption']
matrix = np.array([[0.6, 0.7, 0.6, 0.4, 0.515, 0.7, 0.7, 0.8, 0.6], [0.8, 0.45, 0.7, 0.75, 0.712, 0.6, 0.5, 0.4, 0.3], [0.9, 0.6, 0.8, 0.7, 0.436, 0.6, 0.6, 0.7, 0.5], [0.9, 0.2, 0.6, 0.3, 0.688, 0.3, 0.3, 0.2, 0.3], [0.8, 0.4, 0.7, 0.3, 0.436, 0.4, 0.4, 0.4, 0.5], [0.7, 0.6, 0.5, 0.5, 0.436, 0.5, 0.6, 0.6, 0.7], [0.9, 0.1, 0.3, 0.1, 0.65, 0.2, 0.2, 0.1, 0.1]])
dims = ['novelty_score', 'feasibility_score', 'impact_score', 'mechanistic_plausibility_score', 'clinical_relevance_score', 'data_availability_score', 'reproducibility_score', 'druggability_score', 'safety_profile_score']
if matrix.size:
fig, ax = plt.subplots(figsize=(10, 5))
im = ax.imshow(matrix, cmap='RdYlGn', aspect='auto', vmin=0, vmax=1)
ax.set_xticks(range(len(dims)))
ax.set_xticklabels([d.replace('_score','').replace('_',' ').title() for d in dims],
rotation=45, ha='right', fontsize=8)
ax.set_yticks(range(len(labels))); ax.set_yticklabels(labels, fontsize=7)
ax.set_title('Score dimensions — top hypotheses')
plt.colorbar(im, ax=ax, shrink=0.8)
plt.tight_layout(); plt.show()
else:
print('No score data available')
7. PubMed literature per hypothesis¶
Hypothesis 1: Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation¶
Target genes: FCGRT · Composite score: 0.773
Molecular Mechanism and Rationale
The neonatal Fc receptor (FcRn), encoded by the FCGRT gene, plays a crucial role in antibody pharmacokinetics through its pH-dependent binding mechanism with immunoglobulin G (IgG) antibodies. Under normal physiological conditions, FcRn binds IgG with high affi
In [9]:
print('No PubMed results for hypothesis h-23a3cc07')
No PubMed results for hypothesis h-23a3cc07
Hypothesis 2: Glymphatic System-Enhanced Antibody Clearance Reversal¶
Target genes: AQP4 · Composite score: 0.758
Molecular Mechanism and Rationale
The glymphatic system represents a recently discovered brain-wide clearance mechanism that facilitates the removal of metabolic waste products, including amyloid-beta (Aβ) and tau proteins, through a network of perivascular channels lined by astrocytic endfeet.
In [10]:
lit_data = [{'year': '2024', 'journal': 'Endocrinology', 'title': 'Thyroid Hormone and Alzheimer Disease: Bridging Epidemiology to Mechanism.', 'pmid': '39276028'}]
if lit_data:
df = pd.DataFrame(lit_data)
print(f'{len(lit_data)} PubMed results')
display(df)
else:
print('No PubMed results')
1 PubMed results
| year | journal | title | pmid | |
|---|---|---|---|---|
| 0 | 2024 | Endocrinology | Thyroid Hormone and Alzheimer Disease: Bridgin... | 39276028 |
Hypothesis 3: Synthetic Biology BBB Endothelial Cell Reprogramming¶
Target genes: TFR1, LRP1, CAV1, ABCB1 · Composite score: 0.727
Molecular Mechanism and Rationale
The blood-brain barrier (BBB) represents one of the most formidable obstacles in neurotherapeutics, with its tightly regulated endothelial cells severely limiting drug penetration into the central nervous system. This synthetic biology approach targets the fund
In [11]:
print('No PubMed results for hypothesis h-84808267')
No PubMed results for hypothesis h-84808267
Hypothesis 4: Magnetosonic-Triggered Transferrin Receptor Clustering¶
Target genes: TFR1 · Composite score: 0.719
Molecular Mechanism and Rationale
The transferrin receptor 1 (TfR1) represents a critical gateway for iron transport across the blood-brain barrier (BBB) and serves as an exceptional target for therapeutic delivery to the central nervous system. TfR1 is a homodimeric type II transmembrane glyco
In [12]:
print('No PubMed results for hypothesis h-aa2d317c')
No PubMed results for hypothesis h-aa2d317c
Hypothesis 5: Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides¶
Target genes: APOE, LRP1, LDLR · Composite score: 0.718
Molecular Mechanism and Rationale
The apolipoprotein E4 (ApoE4) isoform represents the most significant genetic risk factor for late-onset Alzheimer's disease, present in approximately 40-65% of patients compared to 15% of the general population. Unlike the protective ApoE2 and neutral ApoE3 is
In [13]:
print('No PubMed results for hypothesis h-b948c32c')
No PubMed results for hypothesis h-b948c32c
Hypothesis 6: Circadian-Synchronized LRP1 Pathway Activation¶
Target genes: LRP1, MTNR1A, MTNR1B · Composite score: 0.714
Molecular Mechanism and Rationale¶
The circadian-synchronized LRP1 pathway activation hypothesis exploits the intricate temporal regulation of the low-density lipoprotein receptor-related protein 1 (LRP1) and melatonin receptor signaling to enhance therapeutic delivery across the blood-brain
In [14]:
print('No PubMed results for hypothesis h-7e0b5ade')
No PubMed results for hypothesis h-7e0b5ade
Hypothesis 7: Piezoelectric Nanochannel BBB Disruption¶
Target genes: CLDN5, OCLN · Composite score: 0.67
Molecular Mechanism and Rationale
The blood-brain barrier (BBB) represents one of the most formidable obstacles in treating neurodegenerative diseases, with tight junctions formed by specialized proteins creating an impermeable seal between brain endothelial cells. The proposed piezoelectric na
In [15]:
print('No PubMed results for hypothesis h-7a8d7379')
No PubMed results for hypothesis h-7a8d7379
8. Knowledge graph edges (246 total)¶
In [16]:
edge_data = [{'source': 'APOE', 'relation': 'associated_with', 'target': 'neurodegeneration', 'strength': 1.0}, {'source': 'LRP1', 'relation': 'associated_with', 'target': 'neurodegeneration', 'strength': 0.82}, {'source': 'OCLN', 'relation': 'encodes', 'target': 'occludin', 'strength': 0.8}, {'source': 'occludin', 'relation': 'maintains', 'target': 'BBB_integrity', 'strength': 0.8}, {'source': 'ABCB1', 'relation': 'encodes', 'target': 'P_glycoprotein', 'strength': 0.8}, {'source': 'claudin_5', 'relation': 'maintains', 'target': 'tight_junctions', 'strength': 0.8}, {'source': 'melatonin_receptor', 'relation': 'controls', 'target': 'circadian_regulation', 'strength': 0.8}, {'source': 'TFR1', 'relation': 'encodes', 'target': 'transferrin_receptor', 'strength': 0.8}, {'source': 'apolipoprotein_E', 'relation': 'regulates', 'target': 'amyloid_clearance', 'strength': 0.8}, {'source': 'AQP4', 'relation': 'encodes', 'target': 'aquaporin_4', 'strength': 0.8}, {'source': 'CAV1', 'relation': 'encodes', 'target': 'caveolin_1', 'strength': 0.8}, {'source': 'caveolin_1', 'relation': 'enhances', 'target': 'transcytosis', 'strength': 0.8}, {'source': 'P_glycoprotein', 'relation': 'mediates', 'target': 'drug_efflux', 'strength': 0.8}, {'source': 'CLDN5', 'relation': 'encodes', 'target': 'claudin_5', 'strength': 0.8}, {'source': 'LRP1', 'relation': 'encodes', 'target': 'LRP1_protein', 'strength': 0.8}, {'source': 'circadian_regulation', 'relation': 'modulates', 'target': 'BBB_permeability', 'strength': 0.8}, {'source': 'LRP1_protein', 'relation': 'mediates', 'target': 'apoE_transport', 'strength': 0.8}, {'source': 'MTNR1A', 'relation': 'encodes', 'target': 'melatonin_receptor', 'strength': 0.8}, {'source': 'transferrin_receptor', 'relation': 'facilitates', 'target': 'receptor_mediated_transcytosis', 'strength': 0.8}, {'source': 'antibody_transcytosis', 'relation': 'treats', 'target': 'Alzheimer_disease', 'strength': 0.8}, {'source': 'FcRn_receptor', 'relation': 'mediates', 'target': 'antibody_transcytosis', 'strength': 0.8}, {'source': 'APOE', 'relation': 'encodes', 'target': 'apolipoprotein_E', 'strength': 0.8}, {'source': 'FCGRT', 'relation': 'encodes', 'target': 'FcRn_receptor', 'strength': 0.8}, {'source': 'MTNR1B', 'relation': 'associated_with', 'target': 'neurodegeneration', 'strength': 0.65}, {'source': 'LDLR', 'relation': 'associated_with', 'target': 'neurodegeneration', 'strength': 0.65}]
if edge_data:
pd.DataFrame(edge_data).head(25)
else:
print('No KG edge data available')
Caveats¶
This notebook uses real Forge tool calls from live APIs:
- Enrichment is against curated gene-set libraries (Enrichr)
- STRING/Reactome/HPA/MyGene reflect curated knowledge
- PubMed literature is search-relevance ranked, not systematic review
The cached evidence bundle is the minimum viable real-data analysis for this topic.